Issues that require pharmacist intervention is knowledge area 3.3 of the 2026 PTCE outline. The outline lists drug utilization review (DUR), adverse drug events, OTC recommendations, therapeutic substitution, misuse, adherence, post-immunization care, allergies and drug interactions.
These are the questions candidates most often get wrong, because the correct answer is usually to involve the pharmacist rather than to act. Most are counter or order-entry scenarios, and each answer cites the federal rule, CDC guidance or product label behind it.
Want the same material as a timed, randomized run instead? Try the timed Patient Safety quiz and the Patient Safety & Quality Assurance domain guide.
